[新型冠状病毒肺炎、管理、治疗及疫苗方法]
[COVID-19, management, therapeutic and vaccine approaches].
作者信息
Matusik Élodie, Ayadi Mériam, Picard Nicolas
机构信息
Département recherche en soins critiques.
Pharmacie, centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes, France.
出版信息
Actual Pharm. 2020 Oct;59(599):27-33. doi: 10.1016/j.actpha.2020.08.007. Epub 2020 Aug 21.
Abstract
While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.
摘要
在2020年初新冠疫情迅速蔓延之际，世界各地的许多科研团队纷纷投入工作。严重急性呼吸综合征冠状病毒2感染的管理基于实验性的非特异性（对症）或特异性（治愈性）治疗方法。疫苗将是长期免疫的关键。
相似文献
1
[COVID-19, management, therapeutic and vaccine approaches].[新型冠状病毒肺炎、管理、治疗及疫苗方法]
Actual Pharm. 2020 Oct;59(599):27-33. doi: 10.1016/j.actpha.2020.08.007. Epub 2020 Aug 21.
2
COVID-19 Outbreak in Malaysia.马来西亚的新冠疫情爆发。
Osong Public Health Res Perspect. 2020 Jun;11(3):93-100. doi: 10.24171/j.phrp.2020.11.3.08.
3
BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?为减轻新冠疫情影响而实施的卡介苗接种策略：炒作还是希望？
Med Drug Discov. 2020 Sep;7:100049. doi: 10.1016/j.medidd.2020.100049. Epub 2020 May 26.
引用本文的文献
1
Viral Hepatitis B and Its Implications for Public Health in DR Congo: A Systematic Review.刚果民主共和国的乙型病毒性肝炎及其对公共卫生的影响：一项系统综述
Viruses. 2024 Dec 25;17(1):9. doi: 10.3390/v17010009.
2
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）/COVID-19 及其相关疗法和疫苗的研究进展，以应对这一新兴的大流行病。
Ann Clin Microbiol Antimicrob. 2020 Sep 2;19(1):40. doi: 10.1186/s12941-020-00384-w.
本文引用的文献
1
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.阿奇霉素联合标准治疗与标准治疗单独用于治疗巴西因重度 COVID-19 住院患者（COALITION II）：一项随机临床试验。
Lancet. 2020 Oct 3;396(10256):959-967. doi: 10.1016/S0140-6736(20)31862-6. Epub 2020 Sep 5.
2
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
3
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.洛匹那韦/利托那韦或阿比多尔治疗成人轻/中度 COVID-19 患者的疗效和安全性：一项探索性随机对照试验。
Med. 2020 Dec 18;1(1):105-113.e4. doi: 10.1016/j.medj.2020.04.001. Epub 2020 May 19.
4
Anakinra for severe forms of COVID-19: a cohort study.阿那白滞素用于重症新型冠状病毒肺炎：一项队列研究。
Lancet Rheumatol. 2020 Jul;2(7):e393-e400. doi: 10.1016/S2665-9913(20)30164-8. Epub 2020 May 29.
5
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
6
Dissecting antibody-mediated protection against SARS-CoV-2.解析针对 SARS-CoV-2 的抗体介导保护作用。
Nat Rev Immunol. 2020 Jul;20(7):392-394. doi: 10.1038/s41577-020-0359-5. Epub 2020 Jun 8.
7
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.恢复期血浆疗法对重症和危及生命的 COVID-19 患者临床改善时间的影响：一项随机临床试验。
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
8
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
9
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.评估静脉用瑞德西韦治疗成人重症 COVID-19 的疗效和安全性：一项 3 期随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.
10
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.从 SARS-CoV 到 SARS-CoV-2：冠状病毒疫苗开发的安全性和广谱性很重要。
Microbes Infect. 2020 Jul-Aug;22(6-7):245-253. doi: 10.1016/j.micinf.2020.05.004. Epub 2020 May 11.
Zotero 插件